The following table provides an overview of the latest patents of H. Lundbeck A/s that has been opposed by its competitors. It provides an insight into the competitive landscape of the industry and highlights the patents that are subject to oppositions.

Patent NumberGrant DateTitleTotal Oppositions
EP2608789Aug 21, 2024Therapeutic Uses Of 1-[2-(2,4-Dimethyl-Phenylsulfanyl)Phenyl]Piperazine1
EP3345604Jun 7, 2023Nalmefene For Reduction Of Alcohol Consumption In Specific Target Populations2
EP3615518Dec 15, 2021Process For The Manufacture Of Vortioxetine Hbr Alpha-Form1
EP3138564Jan 31, 2018Nalmefene For Reduction Of Alcohol Consumption In Specific Target Populations1